79 related articles for article (PubMed ID: 31197555)
1. Survival Differences of Patients with Resected Extraskeletal Osteosarcoma Receiving Two Different (Neo)Adjuvant Chemotherapy Regimens: A Systematic Review and Meta-analysis.
Campos F; Téres R; Sebio A; Bettim BB; Martinez-Trufero J
Clin Oncol (R Coll Radiol); 2023 Dec; 35(12):e720-e727. PubMed ID: 37777356
[TBL] [Abstract][Full Text] [Related]
2. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.
Eilber FC; Eilber FR; Eckardt J; Rosen G; Riedel E; Maki RG; Brennan MF; Singer S
Ann Surg; 2004 Oct; 240(4):686-95; discussion 695-7. PubMed ID: 15383796
[TBL] [Abstract][Full Text] [Related]
3. The Role of Chemotherapy in Extraskeletal Osteosarcoma: A Propensity Score Analysis of the Surveillance Epidemiology and End Results (SEER) Database.
Qi L; Wan L; Ren X; Zhang W; Tu C; Li Z
Med Sci Monit; 2020 Aug; 26():e925107. PubMed ID: 32792473
[TBL] [Abstract][Full Text] [Related]
4. An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma.
Zoccali C; Prencipe U; Ferraresi V; Salducca N
J Orthop Traumatol; 2009 Sep; 10(3):151-4. PubMed ID: 19644649
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma.
Katz D; Boonsirikamchai P; Choi H; Lazar AJ; Wang WL; Xiao L; Park MS; Ravi V; Benjamin RS; Araujo DM
Clin Sarcoma Res; 2012 Jan; 2(1):2. PubMed ID: 22587772
[TBL] [Abstract][Full Text] [Related]
6. A Case of Retroperitoneal Synovial Sarcoma in Pregnancy Treated with Antepartum Doxorubicin plus Ifosfamide Chemotherapy.
Sipe BH; Običan SG; Henderson-Jackson E; Riddle ND; Makanji R; Gonzalez RJ; Brohl AS
Case Rep Oncol Med; 2021; 2021():9982171. PubMed ID: 34336322
[TBL] [Abstract][Full Text] [Related]
7. Primary breast osteosarcoma: A case report and review of the literature.
Omranipour R; Ensani F; Hassanesfahani M
Clin Case Rep; 2021 Nov; 9(11):e05044. PubMed ID: 34815871
[TBL] [Abstract][Full Text] [Related]
8. Construction of an oxidative phosphorylation-related gene signature for predicting prognosis and identifying immune infiltration in osteosarcoma.
Zhou P; Zhang J; Feng J; Wang G
Aging (Albany NY); 2024 Mar; 16(6):5311-5335. PubMed ID: 38506898
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary management for primary uterine osteosarcoma, including gene panel testing: case report and literature review.
Kusanishi T; Tanaka N; Itoi M; Ijiri M; Ebisawa K; Suzuka K; Hagiwara Y; Yonemoto T; Araki A; Itami M
Int Cancer Conf J; 2023 Oct; 12(4):241-247. PubMed ID: 37577351
[TBL] [Abstract][Full Text] [Related]
10. Construction and validation of a prognostic model for osteosarcoma patients based on autophagy-related genes.
Ning B; Liu Y; Xu T; Li Y; Wei D; Huang T; Wei Y
Discov Oncol; 2022 Dec; 13(1):146. PubMed ID: 36586072
[TBL] [Abstract][Full Text] [Related]
11. Effects of neoadjuvant chemotherapy combined with customized tumor-type total knee arthroplasty on immune function and limb function in the treatment of malignant bone tumors around the knee joint.
Zhang X; Lang Z; Wang Y
Pak J Med Sci; 2022; 38(6):1447-1452. PubMed ID: 35991227
[TBL] [Abstract][Full Text] [Related]
12. Unfolded Protein Response-Related Signature Associates With the Immune Microenvironment and Prognostic Prediction in Osteosarcoma.
Zhang Z; Liu X; Cheng D; Dang J; Mi Z; Shi Y; Wang L; Fan H
Front Genet; 2022; 13():911346. PubMed ID: 35754801
[No Abstract] [Full Text] [Related]
13. The Effect of Adjuvant Chemotherapy on Localized Extraskeletal Osteosarcoma: A Systematic Review.
Tsukamoto S; Mavrogenis AF; Angelelli L; Righi A; Filardo G; Kido A; Honoki K; Tanaka Y; Tanaka Y; Errani C
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626164
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ifosfamide combined with liposome doxorubicin on osteosarcoma and its effects on serum IL-10, TNF-α, and IFN-γ in patients with osteosarcoma.
Huang G; Hua S; Liu H; Zhou H; Chen X; Wang Z; Yu W
Am J Transl Res; 2022; 14(2):1288-1296. PubMed ID: 35273730
[TBL] [Abstract][Full Text] [Related]
15. Identifying four DNA methylation gene sites signature for predicting prognosis of osteosarcoma.
Zhang X; Zheng Y; Li G; Yu C; Ji T; Miao S
Transl Cancer Res; 2020 Nov; 9(11):7299-7309. PubMed ID: 35117331
[TBL] [Abstract][Full Text] [Related]
16. A Novel Overall Survival Prediction Signature Based on Cancer Stem Cell-Related Genes in Osteosarcoma.
Xiao B; Liu L; Chen Z; Li A; Xia Y; Wang P; Xiang C; Zeng Y; Li H
Front Cell Dev Biol; 2021; 9():753414. PubMed ID: 34733853
[No Abstract] [Full Text] [Related]
17. Intraperitoneal extraosseous osteosarcoma: a case report and literatures review.
Wang T; Liao S; Ding X; Anil KC; Huang Q; Lin C; Mo J; Tang H; Liu Y
BMC Musculoskelet Disord; 2020 Jul; 21(1):452. PubMed ID: 32653041
[TBL] [Abstract][Full Text] [Related]
18. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma.
Wakamatsu T; Kakunaga S; Takenaka S; Outani H; Hamada K; Imura Y; Hori Y; Naka N; Kudawara I; Yoshikawa H; Ueda T
Int J Clin Oncol; 2019 Oct; 24(10):1311-1319. PubMed ID: 31197555
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
